Rise Nano Optics Lists on CSE After Reverse Takeover, Eyes 2026 Lens Launch
Rise Nano Optics Ltd., headquartered in Haifa, Israel, completed its reverse takeover and began trading under ticker EYE on the Canadian Securities Exchange. The nanotech health company plans to launch its flagship SPECTRAGUARD lenses to filter high-energy wavelengths across Canada and the United States later this year.
1. Listing Details
Rise Nano Optics Ltd. completed a reverse takeover and saw its common shares begin trading on the Canadian Securities Exchange under the ticker EYE. The listing grants the company access to a broader investor base and enhanced market liquidity through the CSE’s competitive fee structure.
2. Product Overview
The Haifa-based company develops SPECTRAGUARD lenses using nanotechnology to filter high-energy wavelengths from everyday surroundings, aiming to reduce vision stress and prevent eye disease. These lenses represent the company’s flagship offering in the emerging health technology segment.
3. Growth Outlook and Capital Access
With its new public status, Rise Nano Optics gains greater access to capital to support product rollouts in Canada and the United States this year. Management expects the listing to accelerate growth, expand global presence, and create long-term shareholder value.